Optimized pharmacotherapeutic management of immune checkpoint inhibitor treatment in metastatic clear-cell renal cell carcinoma

Kannan Sridharan, Giandomenico Roviello, Francesco Massari, Gowri Sivaramakrishnan, Chiara Calandrelli, Matteo Santoni

Open source

DOI
10.1080/14656566.2026.2749651
Published
2026-11-08
Container
Expert Opinion on Pharmacotherapy
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/14656566.2026.2749651,
  title = {Optimized pharmacotherapeutic management of immune checkpoint inhibitor treatment in metastatic clear-cell renal cell carcinoma},
  author = {Kannan Sridharan and Giandomenico Roviello and Francesco Massari and Gowri Sivaramakrishnan and Chiara Calandrelli and Matteo Santoni},
  year = {2026},
  journal = {Expert Opinion on Pharmacotherapy},
  doi = {10.1080/14656566.2026.2749651},
  url = {https://doi.org/10.1080/14656566.2026.2749651}
}

RIS

TY  - JOUR
TI  - Optimized pharmacotherapeutic management of immune checkpoint inhibitor treatment in metastatic clear-cell renal cell carcinoma
AU  - Kannan Sridharan
AU  - Giandomenico Roviello
AU  - Francesco Massari
AU  - Gowri Sivaramakrishnan
AU  - Chiara Calandrelli
AU  - Matteo Santoni
PY  - 2026
JO  - Expert Opinion on Pharmacotherapy
DO  - 10.1080/14656566.2026.2749651
UR  - https://doi.org/10.1080/14656566.2026.2749651
ER  - 

APA

Sridharan, K., Roviello, G., Massari, F., Sivaramakrishnan, G., Calandrelli, C., & Santoni, M. (2026). Optimized pharmacotherapeutic management of immune checkpoint inhibitor treatment in metastatic clear-cell renal cell carcinoma. Expert Opinion on Pharmacotherapy. https://doi.org/10.1080/14656566.2026.2749651

Source records